News · Europe CBD
On 9 February 2026 the Commission terminated the procedure for cannabidiol from Cannabis sativa L. (NF/2022/11411) without adding it to the Union list of novel foods. Incomplete dossiers keep dying. Retail ingestible CBD is still not an authorised EU food.
Under Regulation (EU) 2015/2283, a novel food may only be placed on the market if it is authorised and listed. CBD extracts and isolates intended for food use sit in that framework. When an application lacks required data, the Commission can terminate the procedure without updating the Union list – meaning no authorisation.
The Commission’s public register of terminating decisions includes a 9 February 2026 Implementing Decision closing the file for cannabidiol from Cannabis sativa L. (NF/2022/11411) without a Union-list update. That sits alongside earlier CBD terminations from prior years. Trade coverage in spring 2026 also reported a wider wave of incomplete CBD dossiers being closed.
The same week, EFSA published its provisional safe intake for high-purity CBD as a novel food (~2 mg/day for a 70 kg adult). That is a risk-assessment reference for future evaluations, not a product authorisation and not a green light for every oil on a shop shelf.
Retail presence is not Union-list approval. Until the Commission adds a CBD entry with conditions of use, ingestible CBD remains an unauthorised novel food across the single market – whatever national grey-zone practice looks like on the high street.
Disclaimer: News context for shoppers, not legal or medical advice. Novel food decisions and national enforcement can change. Check current Commission and national guidance before you buy, ship or sell ingestible CBD.
No full Union-list authorisation for CBD as a novel food is in force. The Commission continues to terminate incomplete procedures without approval.
On 9 February 2026 the Commission terminated the procedure for cannabidiol from Cannabis sativa L. without updating the Union list of novel foods.
No. It is a provisional risk-assessment intake for high-purity CBD, not a novel food authorisation.
News
Slovakia removed cannabidiol from its national narcotics list with effect from 1 May 2021, but this did not create a blanket exemption from EU product rules. For ingestible…
Austria is more open on low-THC hemp flowers than Portugal or Greece, yet 2025 tobacco-monopoly practice pushed dried flowers toward licensed tobacconists. AGES still blocks cannabinoid oils and…
Ireland's Food Safety Authority says CBD used as or in food or food supplements is an unauthorised novel food and cannot legally be placed on the EU market.…
The EU Scientific Committee on Consumer Safety finalised advice on CBD in cosmetics on 26 March 2026 and published it on 24 April. Pure CBD is considered safe…
Medical Disclaimer
The information on this website is for general informational purposes only and does not constitute medical advice. CBD products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before using CBD, especially if you are pregnant, nursing, taking medication, or have a medical condition.
CBD legality varies by country and region. In the EU, CBD products containing less than 0.2% THC are generally permitted, but local laws may differ. Verify the legal status in your jurisdiction before purchasing or using CBD products.
This website may contain affiliate links. We may earn a commission from qualifying purchases at no additional cost to you. Affiliate relationships do not influence our editorial content or product recommendations.
Last updated: August 2026
